Text Size:AAA

人 KLK13/Kallikrein 13 基因ORF全长cDNA克隆(表达载体), C-Flag 标签

产品数据评论实验方法
描述: Active  
表达宿主: Human Cells  
  • Slide 1
10199-H08H-20
10199-H08H-10
20 µg 
10 µg 
Add to Cart
反应性: Human  
应用 : 
    10199-MM06-50
    10199-MM06-200
    10199-MM06-100
    10199-MM06-1
    50 µg 
    200 µg 
    100 µg 
    1 mg 
    Add to Cart
    反应性: Human  
    应用 : ELISA  
      10199-RP01-400
      10199-RP01-200
      10199-RP01-100
      400 µg 
      200 µg 
      100 µg 
      Add to Cart
      反应性: Human  
      应用 : ELISA  
        10199-MM01-50
        10199-MM01-200
        10199-MM01-100
        50 µg 
        200 µg 
        100 µg 
        Add to Cart
        反应性: Human  
        应用 : ELISA  
          10199-R001-50
          10199-R001-100
          50 µg 
          100 µg 
          Add to Cart
          反应性: Human  
          应用 : ELISA  
            10199-RP02-50
            10199-RP02-200
            10199-RP02-100
            50 µg 
            200 µg 
            100 µg 
            Add to Cart
            反应性: Human  
            应用 : ELISA  
              10199-T16-50
              10199-T16-200
              10199-T16-100
              50 µg 
              200 µg 
              100 µg 
              Add to Cart

              KLK13/Kallikrein 13 cDNARelated Products

              Related Products

              Featured Reagent Products

              KLK13/Kallikrein 13 cdna-clone 研究背景

              Tissue kallikrein 13 (hK13), also known as KLK-L4 (kallikrein-like gene 4), is a member of the human tissue kallikrein family of serine proteases having diverse physiological functions in many tissues. The KLK13 gene resides on chromosome 19q13.3-4 along with other 14 members in a gene cluster and shares a high degree of homology. KLK13 is a trypsin-like, secreted serine protease expressed specifically in the testicular tissue including prostate, salivary gland, breast, and testis. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and may play a role in metastasis. KLK13 may be involved in the pathogenesis and/or progression of breast and ovary cancers, and is regarded as a novel cancer biomarker. In addition, KLK13 interacts and forms complexes with several serum protease inhibitors, such as alpha2-macroglobulin, and its expression is regulated by steroid hormones.

               KLK13/Kallikrein 13 cdna-clone 参考资料
              请注意:所有产品都是“仅用于科研,而不能用于诊断或治疗用途”